Digital albuterol system feasibility studied in 333 asthma patients with suboptimal control
Can a smart inhaler help people with uncontrolled asthma breathe easier?
A phase 4, open-label, multicenter feasibility study randomized 333 participants aged 13+ with suboptimal asthma control to either the Albut…
A new smart inhaler system tested for 12 weeks to see if it helps people with uncontrolled asthma breathe easier, but results are not yet av…
Phase 2 trial tests amlitelimab add-on therapy in adults with moderate-to-severe asthma
Phase 2 trial tests new asthma drug amlitelimab in adults with moderate-to-severe asthma
A phase 2 randomized controlled trial enrolled 437 adults with moderate-to-severe asthma globally to evaluate amlitelimab versus placebo.
A new asthma drug called amlitelimab is being tested to see if adding it to current treatments can reduce severe asthma attacks in adults wi…
Nurse-driven HFNC weaning protocol cuts therapy duration by 16 hours, hospital stay by 1 day in bronchiolitis infants
Can letting nurses decide when to reduce breathing support help babies with bronchiolitis get home faster?
In infants with severe bronchiolitis, a nurse-driven high-flow nasal cannula (HFNC) weaning protocol significantly reduced median HFNC durat…
A nurse-driven checklist helped babies with severe bronchiolitis get off breathing support 34 hours sooner, cut hospital stays, and kept the…
Phase 2 Study Evaluates Brenipatide for Moderate-to-Severe Asthma
Could a new drug help people with severe asthma breathe easier?
A Phase 2 trial is assessing the safety and efficacy of brenipatide versus placebo in 531 participants with moderate-to-severe asthma.
A new asthma drug trial aims to reduce flare-ups and improve breathing for adults with moderate-to-severe asthma over the next year.
Phase 2b Study Evaluates KT-621 for Eosinophilic Asthma
Can KT-621 help people with severe asthma breathe easier?
A Phase 2b trial is assessing KT-621's efficacy and safety in 264 adults with moderate to severe eosinophilic asthma.
A new drug called KT-621 is being tested to help people with uncontrolled moderate to severe eosinophilic asthma breathe easier by improving…
IMP2ART Pilot Shows Feasibility for Asthma Self-Management in UK Primary Care
Could Better Asthma Management Save You from Unnecessary Doctor Visits?
The IMP2ART pilot cRCT demonstrated feasibility and acceptability of an asthma self-management strategy in UK primary care, with successful …
A new UK strategy helps asthma patients breathe easier and avoid emergency room visits through personalized action plans and regular profess…